Incidence, risk factors, and mortality of pulmonary embolism in the Netherlands (2015–22): sex differences and shifts during the coronavirus disease 2019 pandemic
Open Access
- 2 April 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (28) , 2809-2821
Abstract
Background and Aims: Epidemiology of pulmonary embolism (PE) may have shifted since the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to describe temporal trends in PE epidemiology in the Netherlands since 2015. Methods: Using nationwide data from Statistics Netherlands, all Dutch inhabitants (>16 million) without a history of PE were dynamically identified on 1 January of each year to assemble eight cohorts of PE-free Dutch inhabitants in 2015–22. They were individually followed until the end of that respective year to determine 1-year risk of PE (identified by hospital diagnoses/primary cause of death) and establish relevant risk factors. The PE cases were subsequently studied to determine 1-year all-cause mortality following PE. Multivariable logistic regression with cluster-robust standard errors and robust Poisson regression were respectively employed to evaluate relative differences in PE incidence and mortality between years. Results: Pulmonary embolism incidence in the Dutch population decreased from 2015 to 2019 but markedly increased by 23% (95% confidence interval 20%–26%), 52% (48%–56%), and 7% (4%–9%) in 2020–22 (vs. 2019), respectively. Most traditional PE risk factors remained associated with PE in 2020–22 but generally with a weaker association. Pulmonary embolism mortality was stable until 2019 but then increased by 10% (6%–14%) in 2020 and 9% (6%–13%) in 2021, while the increase [2% (−1% to 6%)] was insignificant in 2022. The above-mentioned changes since 2020 were generally greater in males than females. Conclusions: The seemingly favourable pre-pandemic temporal trends in PE epidemiology in the Netherlands reversed during the COVID-19 pandemic but appear to revert to pre-pandemic levels after 2022.Keywords
Funding Information
- Chinese Government Scholarship (201906380148)
- Leiden University Medical Center
This publication has 33 references indexed in Scilit:
- Description of the clinical and radiological characteristics of pulmonary embolism in COVID-19 vs non–COVID-19 patients: a multicentric cross-sectional study over a 24-month perspectiveJournal of Thrombosis and Haemostasis, 2025
- Epidemiology of pulmonary embolism diagnosis and management among United States emergency departments over an eight-year periodThe American Journal of Emergency Medicine, 2024
- Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death: an analysis of population-wide data from 63 countriesEuropean Journal of Epidemiology, 2022
- Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999–2018Thrombosis Research, 2022
- Routine screening for pulmonary embolism in COVID-19 patients at the emergency department: impact of D-dimer testing followed by CTPAJournal of Thrombosis and Thrombolysis, 2021
- Current practice patterns of outpatient management of acute pulmonary embolism: A post-hoc analysis of the YEARS studyThrombosis Research, 2020
- Age-Stratified National Trends in Pulmonary Embolism AdmissionsChest, 2019
- Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in ChinaChest, 2019
- Current and future burden of venous thrombosis: Not simply predictableResearch and Practice in Thrombosis and Haemostasis, 2018
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007